Nervous System News and Research

Latest Nervous System News and Research

Forest Laboratories' Colobreathe dry powder inhaler receives EMA approval

Forest Laboratories, Inc., an international pharmaceutical manufacturer and marketer, today announced that it has been granted European Medicines Agency (EMA) approval to market Colobreathe dry powder colistimethate sodium for inhalation for treating cystic fibrosis patients aged 6 years and older with chronic lung infection caused by P. aeruginosa.

24 Feb 2012

UBC develops algorithm to predict how and when proteins misfold

Several neurodegenerative diseases - including Alzheimer's and ALS (Lou Gehrig's disease) - are caused when the body's own proteins fold incorrectly, recruit and convert healthy proteins to the misfolded form, and aggregate in large clumps that gum up the works of the nervous system. "For Star Trek fans, this is like the Borg, a fictional race of cyborgs that abduct and assimilate humans and other species," says Steven Plotkin, a biophysicist at the University of British Columbia in Vancouver who studies the process of protein misfolding.

24 Feb 2012

UA researchers identify the likely culprit of epilepsy

Only 10 years ago, deciphering the genetic information from one individual in a matter of weeks to find a certain disease-causing genetic mutation would have been written off as science fiction. It was the time of the Human Genome Project, and it had taken armies of sequencing robots working around the clock for almost a decade to unravel the complete sequence of the human genetic code - referred to as the genome - by churning out the DNA alphabet letter by letter.

24 Feb 2012

Computer-assisted cognitive rehabilitation benefits patients with relapsing-remitting MS

In a new study published in the March issue of Radiology, functional magnetic resonance imaging (fMRI) shows that cognitive rehabilitation changes brain function and improves cognitive performance in patients with relapsing-remitting multiple sclerosis (MS).

23 Feb 2012

Women with migraine more likely to develop depression

New research suggests women who have migraine or have had them in the past are at an increased risk for developing depression compared to women who have never had migraine.

23 Feb 2012

Questcor fourth quarter net sales increase to $75.5 million

Questcor Pharmaceuticals, Inc. today reported financial results for the fourth quarter and full year ended December 31, 2011.

22 Feb 2012

Biocompatible interface scaffolds for improved prosthetics

Sandia National Laboratories researchers, using off-the-shelf equipment in a chemistry lab, have been working on ways to improve amputees' control over prosthetics with direct help from their own nervous systems.

22 Feb 2012

AAN to honor former NASA astronaut with Public Leadership in Neurology Award

The American Academy of Neurology (AAN) and the American Academy of Neurology Foundation (AAN Foundation) have announced that Rich Clifford, former NASA astronaut, is the recipient of the 2012 Public Leadership in Neurology Award.

22 Feb 2012

AAN announces recipients of 2012 scientific research awards

Nearly two dozen scientific research awards are being bestowed on researchers around the world this year by the American Academy of Neurology, the world's largest association of neurologists. The awards will be presented at the American Academy of Neurology's 64th Annual Meeting in New Orleans April 21-28, 2012, at the New Orleans Ernest N. Morial Convention Center.

22 Feb 2012

AAN to honor Tokyo neurologist with Potamkin Prize for AD research

The American Academy of Neurology is awarding its 2012 Potamkin Prize for Research in Pick's, Alzheimer's and Related Diseases to Takeshi Iwatsubo, MD, PhD, with the University of Tokyo School of Medicine. Iwatsubo will receive the award during the Academy's 64th Annual Meeting, April 21-28, 2012, in New Orleans.

22 Feb 2012

ALS Association, AAN to honor KCL neurologist with Essey Award

The American Academy of Neurology and the ALS Association are awarding the 2012 Sheila Essey Award: An Award for ALS Research to Christopher Shaw, MBChB, MD, FRACP, with the Institute of Psychiatry at King's College London. Shaw will receive the award during the Academy's 64th Annual Meeting, April 21-28, 2012, in New Orleans.

22 Feb 2012

Foreign-born Hispanics in the U.S. might have lower risk of stroke

New research finds foreign-born Hispanics now living in the United States appear to be less likely to have a stroke compared to non-Hispanic white people.

22 Feb 2012

AAN, National MS Society to honor Cleveland Clinic researcher with John Dystel Prize

The American Academy of Neurology and the National Multiple Sclerosis Society are awarding the 2012 John Dystel Prize for MS Research to Richard M. Ransohoff, MD, with the Cleveland Clinic. Ransohoff, a member of the American Academy of Neurology and Associate Editor of Neurology, the Academy's medical journal, will receive the award at the Academy's 64th Annual Meeting in New Orleans, April 21-28, 2012.

22 Feb 2012

Referees' stress tolerance does not depend on specific physical condition

All referees feel stress on match days. However, contrary to what you might believe, a joint study by the Catholic University of Brasilia, A Coru-a University and James Cook University in Australia state that the level of stress is not linked to the physical condition of these referees, but to their nervous system. The researchers measured the activity of Spanish football referees on a normal day and on a match day.

22 Feb 2012

BioLineRx BL-7010 may reduce gluten toxicity in patients with celiac disease

BioLineRx, a biopharmaceutical development company, announced the publication of pre-clinical results demonstrating that BL-7010, an orally available treatment for celiac disease, reduces gluten toxicity (the negative effect of gluten on the patient's body).

22 Feb 2012

IDOM researchers overturn textbook view of liver metabolism

A team led by researchers from the Institute for Diabetes, Obesity and Metabolism (IDOM) at the Perelman School of Medicine, University of Pennsylvania, has overturned a "textbook" view of what the body does after a meal.

22 Feb 2012

FDA grants orphan-drug designation to Arno's AR-42 for treatment of meningioma, schwannoma

Arno Therapeutics, Inc. announced today that its investigational compound, AR-42, has been granted orphan-drug designation by the U.S. Food and Drug Administration for the treatment of meningioma and schwannoma of the central nervous system.

21 Feb 2012

S1 submits Lorexys IND application for HSDD and Female Sexual Dysfunction treatment

S1 Pharmaceuticals, Inc. (S1) announced today that it has submitted its Investigational New Drug (IND) application to the U.S. Food and Drug Administration for Phase I-b clinical studies of SIP-104 (Lorexys). Lorexys is the Company's lead drug candidate for the treatment of Hypoactive Sexual Desire Disorder (HSDD) and Female Sexual Dysfunction (FSD).

21 Feb 2012

Infant colic may be an early sign of migraine headache later in life

New research suggests that mothers who experience migraine may be more likely to have a baby with colic than mothers without a history of migraine. Colic is defined as excessive crying in an otherwise healthy infant. The research was released today and will be presented at the American Academy of Neurology's 64th Annual Meeting in New Orleans April 21 to April 28, 2012.

21 Feb 2012

Intraoperative monitoring of spinal cord may help prevent paralysis

The American Academy of Neurology is issuing an updated guideline that recommends monitoring the spinal cord during spinal surgery and certain chest surgeries to help prevent paralysis, or loss of muscle function, related to the surgeries.

21 Feb 2012